Tim West

PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology

Kristopher M. Kirmess, P. Verghese, J. Braunstein, 2024, Diagnostics.

Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care.

K. Blennow, S. Janelidze, S. Palmqvist, 2024, JAMA.

A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer’s Disease

V.Y Aslanyan, Ronald G. Thomas, Marty Farlow, 2024, Alzheimer's research & therapy.